Langue et région
Devise

E-mail*

Veuillez saisir une adresse courriel valide.

Pour envoyer cette propriété à plusieurs personnes, insérez un point-virgule entre l’adresse courriel de chaque destinataire.

Message

956 caractères restants

Hmm, il semble y avoir eu une erreur lors de l’envoi de votre message. Veuillez réessayer.

Votre courriel a été envoyé.

635 Stone Ave 15 230 pi² Bureau Immeuble Paris, TX 75460 6 645 803 $ CAD (436,36 $ CAD/pi²) 6,50% Taux de capitalisation

.mosaic-column{display:inline-block!important;height:100%!important;width:auto!important}.mosaic-tile i{display:none!important}.mosaic-tile img{height:100%!important;width:auto!important}

Certaines informations ont été traduites automatiquement.

Faits saillants de l'investissement

RECENTLY EXTENDED 11 YEAR LEASE TERM EXPIRES DECEMBER 2036
INVESTMENT GRADE TENANT
CONVENIENTLY LOCATED WITH EASY ACCESS TO U.S. INTERSTATE 82 (LOOP 286)

2025 BUILD-TO-SUIT EXPANSION FOR FRESENIUS KIDNEY CARE
ESSENTIAL DIALYSIS OUTPATIENT SERVICE
ATTRACTIVE RENT GROWTH OF 1.64% ANNUALLY (WEIGHTED AVERAGE)

Résumé de l'annonce

The subject property is a two-building Fresenius Medical Care build-to-suit dialysis center and home therapy center. 633 Stone Avenue was constructed in 2013 and contains 10,684 square feet of leasable area. 635 Stone Avenue was constructed in 2008 and is 4,546 square feet. 635 Stone Avenue was recently renovated to accommodate home therapy treatments to accompany the clinic which continues to operate at 633 Stone Avenue. Fresenius recently extended the 15,230 total SF site for an additional 11 YRS on a NN, corporate-guaranteed lease with three five-year renewal options. The lease for 633 Stone Avenue commenced January 1, 2026 and expires December 31, 2036. The lease for 635 Stone Avenue commenced December 25, 2025 and expires December 24, 2036. The extended lease term calls for 1.64% (weighted average) increases annually.
For more than 100 years now, Fresenius has been working to save lives and improve the quality of life of its patients. Fresenius is a premier renal healthcare company completing more than +/-48 million dialysis treatments per year worldwide and has an industry leading network of more than 3,700 clinics across 40+ countries.

Fresenius Paris TX - OM

Faits sur la propriété

Type de vente

Investissement

Type de propriété

Bureau

Sous-type de propriété

Médical

Taille du bâtiment

15 230 pi²

Classe d’immeuble

Année de construction/rénovation

2013/2025

Prix

6 645 803 $ CAD

Prix par pi²

436,36 $ CAD

Taux de capitalisation

6,50%

Revenu net d’exploitation

431 977 $ CAD

Location

Unique

Hauteur du bâtiment

1 étage

Superficie de plancher typique

15 230 pi²

Coefficient d’occupation des sols de l’immeuble

0,18

Taille du lot

1,99 AC

Zone de développement économique

Oui

Zonage

None

Principaux locataires

Soins de santé et assistance sociale
-
-
-

Fresenius Kidney Care originated in 1996 through a merger that created a global leader in renal services. The company operates thousands of dialysis clinics worldwide while also manufacturing essential dialysis equipment and supplies. The integrated business model combines direct patient care with pharmaceutical production. Fresenius Kidney Care maintains a presence in numerous countries through both treatment centers and production facilities, serving a significant population of patients requiring kidney disease management.